Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?
October 9, 2019 | 10.4244/EIJY19M10_01
Showing 1-9 of 9 articles
Coronary interventions
Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial September 10, 2019 | 10.4244/EIJ-D-19-00498
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study August 9, 2019 | 10.4244/EIJ-D-19-00131
Coronary interventions
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication. July 9, 2019 | 10.4244/EIJ-D-18-01190
Coronary interventions
Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions
Interventional cardiology 2018: the year in review April 5, 2019 | 10.4244/EIJ-D-19-00040
Coronary interventions
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial March 17, 2019 | 10.4244/EIJ-D-19-00202
